126 related articles for article (PubMed ID: 17331324)
1. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
3. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
[TBL] [Abstract][Full Text] [Related]
4. Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC.
Kim JS; Kim MS; Park HJ; Lee S; Park JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):936-9. PubMed ID: 17541199
[TBL] [Abstract][Full Text] [Related]
5. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of drug release from pellets coated with HPMC or Surelease.
Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
[TBL] [Abstract][Full Text] [Related]
7. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
Drug Dev Ind Pharm; 2001 May; 27(5):419-30. PubMed ID: 11448049
[TBL] [Abstract][Full Text] [Related]
8. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
Roy P; Shahiwala A
Eur J Pharm Sci; 2009 Jun; 37(3-4):363-9. PubMed ID: 19491027
[TBL] [Abstract][Full Text] [Related]
9. The effect of sodium alginate on physical and dissolution properties of Surelease-matrix pellets prepared by a novel pelletizer.
Kim MS; Kim JS; Hwang SJ
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1631-4. PubMed ID: 17978525
[TBL] [Abstract][Full Text] [Related]
10. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon.
Pandey S; Swamy SMV; Gupta A; Koli A; Patel S; Maulvi F; Vyas B
J Microencapsul; 2018 May; 35(3):259-271. PubMed ID: 29659317
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].
Liang XD; Zheng Y; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):559-64. PubMed ID: 20957015
[TBL] [Abstract][Full Text] [Related]
12. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
13. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
14. Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease intended for colon-specific drug delivery.
Freire C; Podczeck F; Veiga F; Sousa J
Drug Dev Ind Pharm; 2010 Feb; 36(2):161-72. PubMed ID: 19678749
[TBL] [Abstract][Full Text] [Related]
15. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
[TBL] [Abstract][Full Text] [Related]
16. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
Zhang X; Tang X; Yang R
Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
[TBL] [Abstract][Full Text] [Related]
17. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles.
Kim IH; Park JH; Cheong IW; Kim JH
J Control Release; 2003 Apr; 89(2):225-33. PubMed ID: 12711446
[TBL] [Abstract][Full Text] [Related]
18. Development of sustained-release microparticles containing tamsulosin HCl for orally disintegrating tablet using melt-adsorption method.
Cho CH; Min JH; Hwang KM; Park ES
Drug Deliv Transl Res; 2018 Jun; 8(3):552-564. PubMed ID: 29359246
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical and sensory properties of milk supplemented with lactase microcapsules coated with enteric coating materials.
Ahn SI; Lee YK; Kwak HS
J Dairy Sci; 2019 Aug; 102(8):6959-6970. PubMed ID: 31255265
[TBL] [Abstract][Full Text] [Related]
20. Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: optimization by factorial design.
Kshirsagar SJ; Bhalekar MR; Shewale NS; Godbole VP; Jagdale PK; Mohapatra SK
Drug Deliv; 2011 Aug; 18(6):385-93. PubMed ID: 21449831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
